In conclusion, TRPV4 stimulates NPC tumorigenesis by activating the Ca2+/calcineurin/NFAT4-signaling pathway, and the TRPV4/NFAT4 axis is potential therapeutic target for NPC. The gene discussed is TRPV4; the disease is nasopharyngeal carcinoma.